The pharma believes a bispecific antibody developed by China’s Chimagen Biosciences could deplete the malfunctioning B cells that are behind autoimmune diseases like lupus.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,